MX2024003940A - Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso. - Google Patents

Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso.

Info

Publication number
MX2024003940A
MX2024003940A MX2024003940A MX2024003940A MX2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A
Authority
MX
Mexico
Prior art keywords
methods
modified interleukin
subunit proteins
protein
interleukin
Prior art date
Application number
MX2024003940A
Other languages
English (en)
Spanish (es)
Inventor
Von Kreudenstein Thomas Spreter
Ryan Blackler
Original Assignee
Zymeworks Bc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymeworks Bc Inc filed Critical Zymeworks Bc Inc
Publication of MX2024003940A publication Critical patent/MX2024003940A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2024003940A 2021-09-29 2022-09-29 Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso. MX2024003940A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163249685P 2021-09-29 2021-09-29
PCT/CA2022/051445 WO2023050006A1 (en) 2021-09-29 2022-09-29 Modified interleukin p40 subunit proteins and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2024003940A true MX2024003940A (es) 2024-04-22

Family

ID=85780291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024003940A MX2024003940A (es) 2021-09-29 2022-09-29 Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso.

Country Status (9)

Country Link
US (1) US20240228567A1 (https=)
EP (1) EP4408870A4 (https=)
JP (1) JP2024535925A (https=)
KR (1) KR20240068070A (https=)
CN (1) CN118043343A (https=)
AU (1) AU2022355496A1 (https=)
CA (1) CA3232071A1 (https=)
MX (1) MX2024003940A (https=)
WO (1) WO2023050006A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI880235B (zh) 2017-11-28 2025-04-11 日商中外製藥股份有限公司 可調整配體結合活性的配體結合分子
WO2025136986A2 (en) 2023-12-18 2025-06-26 Genzyme Corporation Il-12 loss of potency muteins
WO2026020161A1 (en) 2024-07-19 2026-01-22 Cytomx Therapeutics, Inc. Activatable il-12 constructs and related compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019355971B2 (en) * 2018-10-03 2025-05-08 Xencor, Inc. IL-12 heterodimeric Fc-fusion proteins
JP7773991B2 (ja) * 2020-03-23 2025-11-20 ザイムワークス ビーシー インコーポレイテッド マスクされたｉｌ１２融合タンパク質及びその使用方法

Also Published As

Publication number Publication date
US20240228567A1 (en) 2024-07-11
EP4408870A4 (en) 2025-10-22
JP2024535925A (ja) 2024-10-02
CA3232071A1 (en) 2023-04-06
AU2022355496A1 (en) 2024-05-02
WO2023050006A1 (en) 2023-04-06
CN118043343A (zh) 2024-05-14
EP4408870A1 (en) 2024-08-07
KR20240068070A (ko) 2024-05-17

Similar Documents

Publication Publication Date Title
MX2024003940A (es) Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso.
MY206158A (en) Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer
PH12020500648A1 (en) Il-15 variants and uses thereof
ZA202203254B (en) Immunocytokine comprising heterodimeric protein complex based on il-15/il-15rα
MX2020010910A (es) Proteinas de fusion heterodimericas dirigidas a pd-1 que contienen proteinas de fusion il-15 / il-15ra fc y dominios de union al antigeno pd-1 y usos de los mismos.
AU2019255744A8 (en) IL-15/IL-15Ra heterodimeric Fc fusion proteins and uses thereof
ATE226086T1 (de) Interleukin-2 analoge mit niedriger toxizität zur verwendung in der immuntherapie
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
EA202091754A1 (ru) Пептиды и комбинации пептидов неканонического происхождения для применения в иммунотерапии различных видов рака
WO2021181233A3 (en) Cd80-fc fusion protein and uses thereof
WO2022024024A3 (en) Proteins comprising hla-g antigen binding domains and their uses
DK1572748T3 (da) Humaniseret antistof (H14.18) af muse-14.18-antistof der binder til GD2 og dets fusionsprotein med IL-2
Nielsen et al. Interleukin‐2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes
MX2019010458A (es) Anticuerpos anti-gitr y metodos de uso de los mismos.
WO2008026071A3 (en) Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens
GEP20105111B (en) Rage fusion proteins and methods of use
WO2022026360A3 (en) Monoclonal antibodies against lilrb1 for diagnostic and therapeutic use
WO2025010377A3 (en) Methods of using anti-sp17 immunotherapeutics
MX2024004763A (es) Citocinas heterodimericas fc y usos de las mismas.
MX2022013288A (es) Composiciones y metodos para el tratamiento de proteinopatias por la proteina 43 de union a acido desoxirribonucleico (adn) de respuesta transactiva (tdp-43).
AU2018274215A1 (en) Antibody-cytokine engrafted proteins and methods of use for immune related disorders
WO2025010376A3 (en) Nucleic acids, vectors, and cells that encode anti-sp17 antibodies and other sp17 binding proteins
PH12021552148A1 (en) Cd3 binding molecules
ZA202408121B (en) Anti-human il-4ra antibody and application thereof
CR20220608A (es) Anticuerpos anti-cd200r1 y métodos de uso de estos